{"id":"4cd64409-c178-549e-ae85-b33c0329eff2","stable_key":"c953cca8-774f-596d-b27a-f13c2c0b5fce:dhc-selected-from-a-screen","predicate":"causes","statement":"On screening a heterogeneous group of TRPV1 agonists in conscious rats, dihydrocapsaicin displayed a desirable hypothermic profile with regard to duration, depth and control, and in rats infusion at 0.125, 0.25, 0.50 and 0.75 mg/kg/h caused maximal temperature changes against vehicle of -0.9, -1.5, -2.0 and -4.2 degrees within about one hour until the six hour infusion was stopped, with dose-dependent immediate decreases also in cynomolgus monkeys.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"94c2e3f1-20a7-5b1b-8e41-549386a98279","mechanism_event_label":"Out of a set of receptor agonists, this one gave the most controllable cooling, and the deeper the dose the deeper the drop.","subject":{"id":"6259a8e0-9611-5f60-9e1b-53bbd8eb1afd","slug":"dihydrocapsaicin","display_name":"Dihydrocapsaicin","entity_type_key":"small_molecule"},"object":{"id":"9c65f451-6d72-547e-8b7a-b97fc57c270a","slug":"pharmacological-hypothermia","display_name":"Hypothermia induced by a drug rather than by physical cooling","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"94c2e3f1-20a7-5b1b-8e41-549386a98279","stable_key":"c953cca8-774f-596d-b27a-f13c2c0b5fce:dhc-selected-from-a-screen-event","event_type":"observed_intervention","label":"Out of a set of receptor agonists, this one gave the most controllable cooling, and the deeper the dose the deeper the drop.","description":"On screening a heterogeneous group of TRPV1 agonists in conscious rats, dihydrocapsaicin displayed a desirable hypothermic profile with regard to duration, depth and control, and in rats infusion at 0.125, 0.25, 0.50 and 0.75 mg/kg/h caused maximal temperature changes against vehicle of -0.9, -1.5, -2.0 and -4.2 degrees within about one hour until the six hour infusion was stopped, with dose-dependent immediate decreases also in cynomolgus monkeys.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"61257bae-68e0-5ae5-937a-da7fdd9c4301","slug":"core-body-temperature","display_name":"Core body temperature","entity_type_key":"cellular_process"},"role":"measured_endpoint","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"8e0c61d8-3930-51d5-bce2-25a5edfb797c","slug":"human-trpv1","display_name":"Human transient receptor potential vanilloid 1 / TRPV1","entity_type_key":"protein"},"role":"target_receptor","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"6259a8e0-9611-5f60-9e1b-53bbd8eb1afd","slug":"dihydrocapsaicin","display_name":"Dihydrocapsaicin","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"9c65f451-6d72-547e-8b7a-b97fc57c270a","slug":"pharmacological-hypothermia","display_name":"Hypothermia induced by a drug rather than by physical cooling","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/dihydrocapsaicin-research/20932337.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"add9a23357b3b1d89126189d178c377e3b4934e1c047d4022cf4aa15fdfa6602\", \"start_char\": 0, \"end_char\": 1847, \"text_sha256\": \"add9a23357b3b1d89126189d178c377e3b4934e1c047d4022cf4aa15fdfa6602\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Screening of a heterogeneous group of TRPV1 agonists followed by dose-response studies in three species","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Continuous intravenous infusion of dihydrocapsaicin at 0.125 to 0.75 mg/kg/h in conscious animals","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The reason dihydrocapsaicin rather than capsaicin is the agent used for this purpose: it was selected out of a screen. The calf arm matters because it is the only body mass here comparable to an adult human.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Dihydrocapsaicin research collection; topical membership is not evidence of a direct clinical effect, and dihydrocapsaicin is recorded separately from capsaicin.","comparator":null,"unit":null,"notes":"","entity":{"slug":"dihydrocapsaicin","display_name":"Dihydrocapsaicin","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Rat, cynomolgus monkey and calf","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Out of a set of receptor agonists, this one gave the most controllable cooling, and the deeper the dose the deeper the drop.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[dhc-p20932337] Drug-induced mild therapeutic hypothermia obtained by administration of a transient receptor potential vanilloid type 1 agonist. (2010). https://pubmed.ncbi.nlm.nih.gov/20932337/ DOI: 10.1186/1471-2261-10-51","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Whole body","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"35ba0b28-e3d5-58f9-aa10-66bcfb2f0c7a","evidence_kind":"source_excerpt","locator":"Lines 218-229","start_line":218,"end_line":229,"excerpt":"### dhc-selected-from-a-screen\nOn screening a heterogeneous group of TRPV1 agonists in conscious rats, dihydrocapsaicin displayed a desirable hypothermic profile with regard to duration, depth and control, and in rats infusion at 0.125, 0.25, 0.50 and 0.75 mg/kg/h caused maximal temperature changes against vehicle of -0.9, -1.5, -2.0 and -4.2 degrees within about one hour until the six hour infusion was stopped, with dose-dependent immediate decreases also in cynomolgus monkeys.\nCondition category: normal\nnutrient_topic: Dihydrocapsaicin research collection; topical membership is not evidence of a direct clinical effect, and dihydrocapsaicin is recorded separately from capsaicin.\nplain_language: Out of a set of receptor agonists, this one gave the most controllable cooling, and the deeper the dose the deeper the drop.\norganism: Rat, cynomolgus monkey and calf\ntissue_or_cell_type: Whole body\nexperimental_model: Screening of a heterogeneous group of TRPV1 agonists followed by dose-response studies in three species\nlimitations: The reason dihydrocapsaicin rather than capsaicin is the agent used for this purpose: it was selected out of a screen. The calf arm matters because it is the only body mass here comparable to an adult human.\nexposure: Continuous intravenous infusion of dihydrocapsaicin at 0.125 to 0.75 mg/kg/h in conscious animals\nevidence_span: {\"source_cache\": \"artifacts/dihydrocapsaicin-research/20932337.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"add9a23357b3b1d89126189d178c377e3b4934e1c047d4022cf4aa15fdfa6602\", \"start_char\": 0, \"end_char\": 1847, \"text_sha256\": \"add9a23357b3b1d89126189d178c377e3b4934e1c047d4022cf4aa15fdfa6602\"}\n[dhc-p20932337] Drug-induced mild therapeutic hypothermia obtained by administration of a transient receptor potential vanilloid type 1 agonist. (2010). https://pubmed.ncbi.nlm.nih.gov/20932337/ DOI: 10.1186/1471-2261-10-51","model_system":"Screening of a heterogeneous group of TRPV1 agonists followed by dose-response studies in three species","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [dhc-p20932337] Drug-induced mild therapeutic hypothermia obtained by administration of a transient receptor potential vanilloid type 1 agonist. (2010). https://pubmed.ncbi.nlm.nih.gov/20932337/ DOI: 10.1186/1471-2261-10-51","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"263a8425-969d-5a1b-8a9b-6101ba6a26a7","stable_key":"import-c953cca8-774f-596d-b27a-f13c2c0b5fce","title":"Dihydrocapsaicin: the second capsaicinoid, the hypothermia it is used to induce, what the gut and liver do to it, and what it does without TRPV1 (2026-09-21)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"97d90ff5dc65dc321068c3e2a0525585f32b2e17eb0c6bfa0d9ef26dc2d6c5a3","revision_id":"dbdc1ad7-a05a-579d-b2aa-c4348e3efc40","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}